Studies indicate that memory B cells from MS patients display elevated expressions of CD40 and Human Leukocyte Antigen (HLA)-DR markers, suggesting an increased propensity for antigen presentation by B cells in MS. Here, CD40 is linked to myeloid sarcoma.